RFI JPEO CBRND/JPM CBRN Medical 2024 CBD S&T Conference 1:1 Sessions
Closed Special Notice Posted
- Solicitation number
- W911SR-Medical-CBD-STConference
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Place of performance
- Fort Lauderdale, Florida 33316, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Special Notice is published by the Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground (ACC Aberdeen Proving Ground) for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and its Joint Project Manager for CBRN Medical (JPM CBRN Medical). The notice announces an opportunity for contractors to meet with JPM CBRN Medical representatives at the upcoming Chemical and Biological Defense Science & Technology (CBD S&T) Conference in December 2024.
The purpose of this Special Notice is to identify contractors with capabilities in areas such as new vaccine platforms, host-directed therapeutics, and medications for chemical or radiological injuries that may be effectively repurposed for CBRN defense purposes. JPM CBRN Medical is interested in meeting with these contractors at the CBD S&T Conference to discuss potential collaboration and acquisition opportunities. The deadline to sign up for a one-on-one meeting slot is November 8, 2024. There are no set-asides or eligibility criteria specified, as the notice is open to any interested parties attending the conference.
Notice text
CBD RFI
JPEO-CBRND JPM Medical
Do you have a capability that enables Chemical, Biological, Radiological and Nuclear Defense (CBRND)? Will you be attending the Chemical and Biological Defense Science & Technology (CBD S&T) Conference 2-5 December 2024?
JPM CBRN Medical, within the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND)serves as the Defense Department’s (DoD) premier program management office for the development and acquisition of safe, effective, and innovative medical solutions to combat CBRN threats to service members. JPM CBRN Medical leads medical countermeasure (MCM) development for vaccines, diagnostics, and therapeutics, which are critical elements to a multi-layered defense strategy.
If you have a capability or technology in the following areas:
- New vaccine platforms
- Host-directed therapeutics
- Medications that may be effective for Chemical or Radiological injuries
- Potential for repurposing FDA approved or advanced development drugs for CBD purposes.
We’d like to meet with you.
Please visit the JETT registration page to sign up for a time slot to meet with us at https://jacks.jpeocbrnd.army.mil/JETT
Looking forward to seeing you in Ft. Lauderdale at the 2024 CBD S&T Conference! Link to register: https://www.dtra.mil/About/Mission/Research-and-Development/#:~:text=The%20Chemical%20and%20Biological%20Defense%20Science%20&%20Technology
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity